Table 2. Rate of contrast-induced nephropathy (CIN) by various patient demographic and clinical characteristics.
CIN, contrast-induced nephropathy; OR, odds ratio; CI, confidence interval
**Benchmark; *Significant at 5%
| Characteristics | Base (N) | CIN rate, % (n) | OR (95% CI) | p-Value |
| Total | 282 | 13.1% (37) | - | - |
| Gender | ||||
| Male | 193 | 15.5% (30) | 2.16 (0.91-5.12) | 0.076 |
| Female** | 89 | 7.9% (7) | ||
| Age (years) | ||||
| 30 to 55 years | 120 | 12.5% (15) | 0.91 (0.45-1.84) | 0.791 |
| 56 to 70 years** | 162 | 13.6% (22) | ||
| Hypertension | ||||
| Hypertensive | 222 | 14.4% (32) | 1.85 (0.69-4.98) | 0.216 |
| Non-hypertensive** | 60 | 8.3% (5) | ||
| Diabetes mellitus | ||||
| Diabetic | 96 | 19.8% (19) | 2.3 (1.14-4.63) | 0.017* |
| Non-diabetic** | 186 | 9.7% (18) | ||
| Smoking | ||||
| Smokers | 78 | 12.8% (10) | 0.96 (0.44-2.1) | 0.926 |
| Non-smokers** | 204 | 13.2% (27) | ||
| Contrast amount used (mL) | ||||
| >200 mL | 36 | 27.8% (10) | 3.12 (1.36-7.17) | 0.005* |
| ≤200 mL** | 246 | 11% (27) | ||